Mettler-Toledo International (NYSE:MTD) Given New $1,550.00 Price Target at Barclays

Mettler-Toledo International (NYSE:MTD) had its price objective lowered by stock analysts at Barclays from $1,600.00 to $1,550.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price objective would indicate a potential upside of 9.57% from the company’s current price.

A number of other brokerages also recently weighed in on MTD. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 8th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a report on Monday. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective for the company. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Finally, Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1,441.67.

Mettler-Toledo International Trading Up 1.5%

Shares of MTD traded up $20.93 during mid-day trading on Monday, reaching $1,414.57. 72,311 shares of the stock traded hands, compared to its average volume of 163,267. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The company has a market cap of $28.90 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 4.50 and a beta of 1.40. The firm has a fifty day moving average price of $1,402.13 and a 200 day moving average price of $1,293.95.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The firm’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the company earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 1,895 shares of the stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at $7,696,789.76. This represents a 26.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Patrick Kaltenbach sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the transaction, the chief executive officer owned 3,670 shares in the company, valued at approximately $5,367,375. The trade was a 35.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 19,565 shares of company stock valued at $28,683,737. 0.77% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc raised its holdings in shares of Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares in the last quarter. SJS Investment Consulting Inc. lifted its holdings in shares of Mettler-Toledo International by 2,700.0% during the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 27 shares during the last quarter. WPG Advisers LLC bought a new stake in Mettler-Toledo International in the first quarter worth $41,000. NewSquare Capital LLC grew its position in Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 17 shares during the last quarter. Finally, MV Capital Management Inc. grew its holdings in shares of Mettler-Toledo International by 50.0% during the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after buying an additional 12 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.